Observations from GCP Sponsor Inspections
Kevin Anderson, Director, Global Clinical Operations, Alexion Pharmaceuticals, offers a perspective on what he has...
Read More...
Focus:
-
![]()
Is the GAIN Act Stimulating Antibiotic R&D?
Christopher J. Pace, PhD, Director of Infectious Diseases, GlobalData, assesses the impact of the GAIN...
Read More...
-
![]()
The Future of Pfizer’s $5B Brand is in Jeopardy
Maura Musciacco, MSc, Neurology & Ophthalmology Director, GlobalData, assesses what the future holds for Pfizer’s...
Read More...
-
![]()
The Top 5: November 2018
CTA highlights the best articles from the month of November 2018
Read More...
-
![]()
Expert Insights: Abbvie’s EU Outlook Dims as Discounts Deepen on Humira Biosimilars
Rose Joachim, PhD, Immunology Analyst, GlobalData, examines the impact of newly approved biosimilars on AbbVie’s...
Read More...
-
![]()
The Ongoing Fight Against Diabetes
On World Diabetes Day, CTA’s Harry Parsons delves in to the disease, looking at the...
Read More...
-
![]()
How to Conduct a Diabetes Trial – Lessons Learned
Jacqueline Mardell, Ascendis Pharma, recounts experiences from a multinational type 2 diabetes trial and draws...
Read More...
-
![]()
Surveying the Challenges of Preclinical Development
CTA’s Adeola Coker delves into the key issues facing preclinical trials ahead of Arena International’s...
Read More...
-
![]()
Industry Viewpoints: The Continual Rise of Direct-to-Patient
Michael Sparozic, Lead Trial Supply Operations Manager, Sanofi, address the merits of direct-to-patient shipping to...
Read More...
-
![]()
Patient-Centric Trials of the Future
Robert Greene, Founder and President, HungerNdThirst Foundation, looks at patient-centric trials of the future
Read More...
